LeMaitre Vascular LMAT Increase Decrease In Inventory And Other Deferred Costs
Increase Decrease In Inventory And Other Deferred Costs at other companies
Other financials
Where this comes from
Reported directly by LeMaitre Vascular in its filing.
Tagged under the XBRL concept ck0001158895:IncreaseDecreaseInInventoryAndOtherDeferredCosts.
The official record: LeMaitre Vascular’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about LeMaitre Vascular's increase decrease in inventory and other deferred costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is LeMaitre Vascular's increase decrease in inventory and other deferred costs?
- LeMaitre Vascular (LMAT) reported increase decrease in inventory and other deferred costs of $1.39M in Q1 2026.
- How has LeMaitre Vascular's increase decrease in inventory and other deferred costs changed year-over-year?
- LeMaitre Vascular's increase decrease in inventory and other deferred costs increased by 4.3% year-over-year, from $1.33M to $1.39M.
- What does increase decrease in inventory and other deferred costs mean?
- This metric tracks the net change in inventory levels and associated deferred costs, reflecting the company's investment in working capital to support future sales. It provides insight into supply chain management, production scaling, and the balance between maintaining sufficient stock and minimizing holding costs.